Unacknowledged Casualties — For the Veteran
It Was Not You.
It Was What They Did
To Your Brain.
If you served in East Timor or Bougainville and were given mefloquine or tafenoquine, this page is written directly for you. What you became was not who you are. What happened was not your fault. And the shame you have been carrying belongs somewhere else entirely.
Before you read another word on this page: If you have spent years — or decades — believing that what happened in your home was a reflection of your character, your weakness, or your failure as a person, this page asks you to pause on that belief. Not to excuse anything. Not to erase anything. But because that belief may be the most significant thing the system got wrong about you — and it has cost you enough already.
Many veterans who were administered mefloquine or tafenoquine during ADF deployments returned home as someone their families — and they themselves — did not recognise. The rage that came from nowhere. The paranoia that targeted the people closest to them. The blackouts. The nightmares that crossed into waking. The feeling of watching yourself from outside, unable to stop what was happening.
They were told it was PTSD. They were given medications that did not work. They were enrolled in therapies calibrated to combat trauma — not to the pharmacological injury that was actually driving their symptoms. And many of them have lived, ever since, with the weight of what happened during those years, carrying a guilt and a grief that the system never gave them the tools to understand.
This page provides those tools. Not comfort. Not absolution. Understanding — precise, clinically grounded, and long overdue.
What the Drugs Actually Did to Your Brain
Mefloquine and tafenoquine are quinoline compounds that, at toxic concentrations, cause direct neurological injury to specific brain regions. This is not a theory. It is documented in three decades of peer-reviewed research, confirmed by the FDA's own black box warning, and established in the laboratory findings of the same institution — WRAIR — that developed both drugs.
The injury is not to the part of the brain responsible for values, or character, or love for your family. It is to the parts responsible for regulating those values — for keeping behaviour aligned with who you actually are. That distinction matters more than anything else on this page.
The Limbic System
What it controls — What its injury producesThe limbic system regulates emotional responses, threat detection, impulse control, empathy, and the modulation of fear and rage. It is the system that, under normal function, keeps the feeling of rage proportionate to the situation — and keeps it from becoming action. Quinoline toxicity at the doses used in ADF trials can damage the limbic system's regulatory function. When that function is compromised, the brain's threat-response fires without adequate inhibition. Rage episodes occur that feel, to the person experiencing them, as though they are happening from outside — because neurologically, the inhibitory system that would normally moderate them is not working. This is not a choice. It is a malfunction in the brain's regulatory architecture, produced by a drug.
The Brainstem
What it controls — What its injury producesThe brainstem governs the autonomic nervous system — the system that controls the body's state of arousal, the fight-or-flight response, and the baseline level of threat-readiness. Brainstem toxicity from quinoline compounds can lock the nervous system in a chronic state of hyperarousal: a body that cannot return to baseline, that interprets ordinary domestic stimuli as threats, that is permanently on the edge of a response designed for combat. Living in that state for months and years does not make a person violent. But it removes the physiological margin between a stimulus and a response — the space in which conscious choice normally operates.
The Vestibular System
What it controls — What its injury producesThe vestibular system manages balance, spatial orientation, and the brain's sense of physical stability. Quinoline toxicity to the vestibular system produces chronic dizziness, disorientation, and disequilibrium — symptoms that can persist for years or become permanent. These physical symptoms are not separate from the behavioural effects. Chronic physical distress compounds anxiety, reduces tolerance for ordinary stimuli, and adds a layer of uncontrollable physiological suffering to an already compromised neurological state. The FDA noted that vestibular effects may persist long after the drug is stopped, or become permanent. For many veterans, they have.
The 2013 FDA black box warning states explicitly that mefloquine may cause neuropsychiatric adverse reactions that persist after the drug is discontinued, and may in some cases become permanent. WRAIR's own 2009 laboratory findings established tafenoquine as more neurotoxic than mefloquine. The peer-reviewed literature on mefloquine intoxication syndrome (Ritchie, Block and Nevin, 2013) identifies explosive rage, paranoid ideation, dissociation, and personality change as characteristic features — not of a person's character, but of a pharmacological injury to specific brain systems.
From Drug to Brain to Behaviour: The Direct Connection
The following table maps the documented neuropsychiatric effects of quinoline toxicity — formally listed in the mefloquine product data sheet and confirmed in the peer-reviewed literature — to the behavioural consequences that veterans and their families have reported. Every entry in the left column is a recognised pharmacological effect. Every entry in the right column is its human consequence, in a home, with the people who mattered most.
| Documented Drug Effect | Neurological Mechanism | What It Looked Like at Home |
|---|---|---|
| Paranoid ideation | Limbic threat-detection system firing without inhibition | Unfounded accusations of infidelity, belief that the partner was conspiring against the veteran, surveillance of a person who posed no threat |
| Explosive rage | Loss of limbic inhibitory control over the threat-response | Sudden, disproportionate, terrifying anger — often with no memory of the episode afterward, or distress at the gap between the behaviour and the veteran's own values |
| Dissociative episodes | Limbic dysregulation producing temporary disconnection from conscious awareness | Acting in ways the veteran had no memory of — including during sleep, when violent behaviour occurred without conscious intent or subsequent recall |
| Personality change | Cumulative injury to limbic regulatory systems altering affective processing | Becoming, over time, someone unrecognisable to the family — and to the veteran themselves. Not a gradual drift in character. A pharmacological alteration in the systems that express character. |
| Hyperarousal and hypervigilance | Brainstem locked in chronic fight-or-flight state | Interpreting a normal household as a threat environment — controlling exits, reacting to ordinary sounds with alarm, restricting family members' movements under the logic of a nervous system that could not stand down |
| Affective flattening | Limbic injury reducing the capacity for emotional responsiveness | Emotional withdrawal — being present in the household but unable to connect, respond, or offer warmth. Experienced by the family as abandonment. Experienced by the veteran as a loss they could not explain or reverse. |
| Abnormal dreams and sleep disturbance | Neurological disruption of sleep architecture and REM regulation | Night terrors producing violent movement during sleep — striking out, vocalising, injuring a bed partner without any waking awareness |
| Suicidal ideation | Limbic dysregulation and neurochemical disruption of mood-regulation systems | A level of internal suffering that the veteran could not communicate, could not have treated correctly under a PTSD diagnosis, and that the people around them could not reach — because no one knew what was actually causing it |
What this is not — and why that matters
Not a Character Failure
The behaviour that occurred in these households was not an expression of who the veteran is. It was an expression of what a drug did to the systems that regulate who the veteran is. Those are not the same thing — and the difference is not semantic. It is the difference between a person who is dangerous and a person with an injury that produced dangerous behaviour.
Not Inevitable
The neurological injury that drove this behaviour was never inevitable. It was the result of a specific institutional decision — to administer potent neurotoxic drugs at doses exceeding approved limits, without adequate informed consent, and without the follow-up care that a clinical trial requires. None of that was the veteran's choice. All of it was someone else's.
Not Untreatable — But Never Correctly Treated
Quinoline-induced acquired brain injury is not the same as PTSD, and it does not respond to the same treatments. SSRIs, trauma-focused therapy, and the frameworks applied under PTSD misdiagnosis were calibrated to the wrong condition. The veteran who spent years in treatment that did not work was not treatment-resistant. They were being treated for something they did not have, for an injury no one had correctly identified.
The man who came home was not the man who left. That was not weakness. That was not failure. That was what mefloquine and tafenoquine did to a brain that had no warning, no defence, and no one in the system prepared to tell the truth about it.Unacknowledged Casualties Research Report, 2026
The Man Who Left, and What Was Done to Him
Many veterans find it useful to hold two versions of themselves in mind — not as a way of avoiding responsibility, but as a way of understanding precisely what happened and where the origin of the harm actually sits.
Before Deployment
A person with values, relationships, a capacity for love and connection. Someone who chose to serve. Whatever difficulties existed in that person's life before deployment, they were that person's own — shaped by their history, their choices, their character. That person is still there. The injury did not replace them. It built a wall between them and the systems that allowed them to act like themselves.
The Drug Administration
Mefloquine or tafenoquine was administered — in many cases as part of a formal AMI clinical drug trial, often at doses exceeding approved limits, and without the full informed consent that trial conditions require. The veteran did not choose this. They were not told what the drug might do. They were soldiers following orders in a medical context they had no reason to question.
The Neurological Injury
The drug concentrated in brain regions including the limbic system, brainstem, and vestibular system. For veterans with poor or intermediate CYP2D6 metabolism — estimated at 12 to 23 percent of the population — the drug could not be cleared before toxic concentrations accumulated. The injury this produced was not immediately visible. It manifested over time, in behaviour, in relationships, in a household that gradually became unrecognisable.
The Misdiagnosis
The veteran presented to a medical system that had no framework for quinoline-induced acquired brain injury. The symptom profile — rage, paranoia, dissociation, hyperarousal, sleep disturbance — was indistinguishable from PTSD on standard psychiatric assessment. PTSD was diagnosed. The wrong treatment was applied. The neurological substrate of the behaviour was never addressed. The behaviour continued.
The Consequences — and the Guilt
Real harm occurred in these households. That harm is acknowledged fully in this report. The guilt that veterans carry about that harm is real too — and it reflects the values of the person who existed before and beneath the injury. But guilt built on the belief that the harm was purely a character failure is guilt built on a false premise. Understanding what actually happened does not erase what occurred. It locates it — and that changes everything about where the work of accountability must go.
What You May Have Been Told — and What Is Actually True
Over the years, veterans affected by quinoline toxicity have encountered a series of messages from the system — from clinicians, from DVA, from culture, and sometimes from themselves — that have shaped how they understand what happened. Many of those messages are wrong. Not in ways that excuse the harm. In ways that locate it incorrectly, and that have caused veterans to carry a weight that does not fully belong to them.
The guilt many veterans carry is, in a specific sense, evidence of who they actually are — because it reflects the values of the person beneath the injury. But guilt that rests on a false account of causation is guilt that cannot be resolved, because it is answering the wrong question. Understanding the pharmacological origin of what happened is not the end of a reckoning. It is the beginning of one that is accurate enough to actually lead somewhere.
What This Means for You Now
Understanding the neurological origin of what happened is not the end of anything. It is a beginning — of a more accurate account of your own life, of a more appropriate claim on the system that caused this, and of a path toward support that is calibrated to what actually happened to you.
- You may never have had a correct diagnosis. If you were diagnosed with PTSD and treated under that framework without improvement, it is worth pursuing assessment by a specialist with expertise in acquired brain injury and neurotoxicology — not only trauma psychiatry.
- Your DVA claim may have been assessed against the wrong condition. The SOP gap for acquired brain injury is a known and documented problem. The QVFA and veteran advocacy organisations can advise on how to reframe a claim in light of the Royal Commission's 2024 findings and the emerging brain injury program.
- CYP2D6 testing may be relevant to your case. If you have poor or intermediate CYP2D6 metabolism, this is a biological marker of increased susceptibility to quinoline neurotoxicity. It is not diagnostic on its own — but it is relevant evidence that has not been part of most veterans' medical records to date.
- You were a clinical trial subject. If you were administered tafenoquine or mefloquine in the ADF East Timor or Bougainville context, you may have been enrolled in an AMI clinical drug trial. As a trial subject, you have specific legal rights — including rights relating to informed consent, duty of care, and access to your trial records — that standard DVA claims processes do not address.
- The shame you have been carrying was always partly the system's to hold. It is not possible to give it back all at once. But it is possible to begin placing it where it belongs — with the institutions that made the decisions, concealed the evidence, and failed in their duty of care to you and to your family.
- You are not alone, and you are not the last. The QVFA, the peer-reviewed literature, the Senate submissions, and the Royal Commission findings all confirm that what you experienced was part of a pattern — a pattern produced by institutional decisions, not by the individual failings of the men who were given these drugs. That matters. It means there is a collective claim here, not only a personal one.
Where to go from here
Getting the Right Diagnosis
What a correct neurological assessment looks like, which specialists to seek, and how to reframe your DVA claim if you have been misdiagnosed with PTSD.
Your Rights as a Trial Subject
What being enrolled in an AMI drug trial means for your legal rights, how to obtain your trial records, and what the Commonwealth's duty of care means for your situation.
Navigating DVA After the Royal Commission
What the 2024 findings actually mean for your claim, how the emerging brain injury program may affect your entitlements, and what advocacy organisations can do for you now.
Understanding What Happened to Your Family
A page for veterans who know something went wrong at home and want a framework for understanding it — without blame, and with clinical honesty about what the drugs produced.
It was not you. It was never only you. The rage, the paranoia, the dissociation, the personality that your family did not recognise — these were pharmacological events in a neurologically injured brain. They had a cause. That cause has a name. And the institution responsible for that cause has not yet answered for it.
You have carried this long enough. The understanding you were always owed is here. What you do with it is yours to decide — but you do not have to decide it alone, and you do not have to decide it in the dark any longer.
Unacknowledged Casualties — Research Report 2026